covid-19 fda - Search News

Order byBest matchMost fresh

FDA Will Approve COVID-19 Vaccine

Digest more

Here's what to know about the FDA's COVID-19 vaccine changes

COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration.

· 5h

STAT · 1d

5 burning questions on the FDA’s new Covid-19 vaccine framework

Infectious Disease Advisor · 5h

FDA’s New COVID-19 Vaccine Approval Policy May Limit Future Access

The FDA plans to limit access to covid vaccines. Here’s why that’s not all bad.

Covid vaccines will soon be required to go through more rigorous trials to ensure that they really are beneficial for people who aren’t at high risk.

MIT Technology Review · 10h

· 1d

FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a public health expert explains the new rules

STAT · 3h

FDA gives Covid vaccine manufacturers instructions for next fall’s shot

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 1d

· 4h

COVID shots should target newer strains of JN.1 variant, US FDA advisers say

· 20h

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

1hon MSN

The New Covid-19 Jab Policy Wasn’t Up for Debate at the FDA’s Vaccine Meeting. Major Questions Remain.

The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine access, and medical ethics.

2don MSN

Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk individuals

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the virus, and those older than age 65.

BioSpace6h

FDA Vaccine Advisors Agree on COVID-19 Vaccine as New Framework Looms as ‘Elephant in the Room’

The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.